investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Validating the eCyPA/CD147 signaling complex for myeloma therapy
Ruben D Carrasco
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Pierfrancesco Tassone
Magna Graecia University
Catanzaro, Italy
Jarrod A Marto
Dana-Farber Cancer Institute
Boston, United States
James E Bradner
Dana-Farber Cancer Institute
Boston, United States
James A Decaprio
Dana-Farber Cancer Institute
Boston, United States
Diovanni Luigi
Dana-Farber Cancer Institute
Boston, United States
Constantine S Mitsiades
Dana-Farber Cancer Institute
Boston, United States
Kenneth C Anderson
Dana-Farber Cancer Institute
Boston, United States
Ruben D Carrasco
Dana-Farber Cancer Institute
Boston, United States
Related projects
Catriona HM Jamieson
(PQC2) Niche-responsive RNA editing by ADAR1 in dormant multiple myeloma initiating cell maintenance
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Ralph D Sanderson
Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
David L Woodland
Immune Evolution in Cancer
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
William Figg
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Jetze J Tepe
Characterization of Non-Competitive Proteasome Binding
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Tracy L Mcgaha
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Kelvin P Lee
CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
Conor C Lynch
Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma
Multiple myeloma and immunoproliferative diseases
Hematology and hematologic malignancies
